The acquisition of Wyeth by its rival and drug manufacturer of US – Pfizer has made big news in the industry. The deal which costs around $68bn (£49.8bn) was announced by the board of Pfizer, on 26th January 2009. The Cadwalader Wickersham & Taft played a major role in the entire acquisition plan and process. […]